XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense Recognized
Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(in thousands)
Research and development
$585 $976 $2,613 $3,674 
General and administrative
648 1,035 2,419 3,244 
Total stock-based compensation
$1,233 $2,011 $5,032 $6,918 
Schedule of Weighted -average Valuation Assumptions
The fair value of stock options granted during the three and nine months ended September 30, 2025 and 2024 was calculated on the date of grant using the following weighted-average assumptions:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Risk-free interest rate
3.9 %4.3 %4.4 %4.0 %
Expected term (in years)
5.56.05.96.0
Expected annual dividend yield
— %— %— %— %
Expected volatility
96.9 %91.9 %95.4 %92.6 %
Summary of Stock Option Activity
The following table summarizes stock option activity during the nine months ended September 30, 2025: 
Options Outstanding
Number of OptionsWeighted-Average Exercise Price per ShareWeighted-Average Remaining
Contractual Life
(in years)
Aggregate Intrinsic Value (in millions)
Outstanding at December 31, 20247,634,937 $6.24 
Granted
3,390,691 $1.49 
Exercised
— $— 
Cancelled
(834,315)$4.49 
Outstanding at September 30, 202510,191,313 $4.80 7.31$1.7 
Exercisable at September 30, 20255,948,176 $6.55 6.20$0.3